15 | Clopidogrel (Plavix)FDA Link
07/2021
-
04/2005 |
11 | Adenosine Triphosphate (ATP)IBA
11/2019
-
07/2003 |
10 | CollagenIBA
01/2020
-
01/2003 |
10 | ThrombinFDA Link
01/2020
-
01/2003 |
8 | IntegrinsIBA
05/2022
-
07/2004 |
8 | Adenosine Diphosphate (ADP)IBA
05/2020
-
01/2003 |
7 | FibrinIBA
01/2020
-
01/2004 |
6 | Glycoproteins (Glycoprotein)IBA
07/2021
-
10/2006 |
5 | ferric chlorideIBA
05/2022
-
01/2003 |
5 | Hemostatics (Antihemorrhagics)IBA
01/2022
-
09/2007 |
5 | NucleotidesIBA
08/2020
-
05/2011 |
5 | Purinergic P2Y1 ReceptorsIBA
01/2020
-
07/2003 |
5 | CationsIBA
01/2019
-
08/2003 |
4 | Proteins (Proteins, Gene)FDA Link
10/2020
-
01/2003 |
4 | Apolipoproteins E (ApoE)IBA
02/2015
-
08/2008 |
4 | Thromboplastin (Tissue Factor)IBA
03/2010
-
01/2003 |
3 | Serotonin (5 Hydroxytryptamine)IBA
12/2021
-
01/2018 |
3 | Purinergic Receptors (Receptors, Purine)IBA
05/2020
-
01/2006 |
3 | Purinergic P2X1 ReceptorsIBA
01/2019
-
07/2005 |
3 | Ion Channels (Ion Channel)IBA
01/2019
-
07/2003 |
3 | LipidsIBA
01/2019
-
01/2003 |
3 | Purinergic P2 Receptors (ADP Receptor)IBA
05/2016
-
01/2006 |
3 | Ticlopidine (Ticlid)FDA LinkGeneric
09/2012
-
11/2005 |
3 | Epinephrine (Adrenaline)FDA LinkGeneric
04/2012
-
01/2003 |
2 | LipopolysaccharidesIBA
05/2022
-
01/2015 |
2 | Fibronectins (Fibronectin)IBA
05/2022
-
11/2015 |
2 | Fibrinogen (Factor I)FDA Link
07/2021
-
10/2020 |
2 | CytokinesIBA
07/2021
-
01/2017 |
2 | Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
07/2021
-
01/2020 |
2 | CalciumIBA
08/2020
-
03/2010 |
2 | Biological ProductsIBA
01/2019
-
11/2016 |
2 | 4,4,',4'',4'''- (carbonylbis(imino- 5,1,3- benzenetriylbis(carbonylimino)))tetrakis(benzene- 1,3- disulfonate)IBA
01/2019
-
07/2005 |
2 | IsoantibodiesIBA
09/2018
-
01/2018 |
2 | Pharmaceutical PreparationsIBA
01/2018
-
02/2015 |
2 | HirudinsIBA
05/2016
-
04/2012 |
2 | 2- iodo- N(6)- methyl- (N)- methanocarba- 2'- deoxyadenosine- 3',5'- bisphosphateIBA
05/2016
-
02/2006 |
2 | AnticoagulantsIBA
02/2015
-
08/2011 |
2 | Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2015
-
09/2010 |
2 | cangrelorIBA
09/2012
-
03/2008 |
2 | Prasugrel HydrochlorideFDA Link
09/2012
-
03/2008 |
2 | TicagrelorIBA
09/2012
-
03/2008 |
2 | vasodilator-stimulated phosphoproteinIBA
08/2012
-
01/2011 |
2 | ThienopyridinesIBA
08/2012
-
03/2008 |
2 | Nonmuscle Myosin Type IIAIBA
04/2012
-
04/2009 |
2 | Adenosine (Adenocard)FDA LinkGeneric
05/2011
-
01/2004 |
2 | von Willebrand FactorIBA
06/2009
-
07/2004 |
2 | GTP-Binding Proteins (G-Protein)IBA
03/2008
-
01/2006 |
2 | Platelet Glycoprotein GPIIb-IIIa ComplexIBA
09/2007
-
07/2006 |
1 | Immunoglobulins (Immunoglobulin)IBA
12/2021 |
1 | Monoclonal AntibodiesIBA
12/2021 |
1 | Fluoxetine (Prozac)FDA LinkGeneric
12/2021 |
1 | Serotonin ReceptorsIBA
12/2021 |
1 | sarpogrelateIBA
12/2021 |
1 | Interleukin-10 (Interleukin 10)IBA
07/2021 |
1 | Interleukin-6 (Interleukin 6)IBA
07/2021 |
1 | Peroxidase (Myeloperoxidase)IBA
07/2021 |
1 | BuffersIBA
01/2021 |
1 | Blood Proteins (Serum Proteins)IBA
10/2020 |